Open Access Pre-publication history

A prospective, non-randomized phase II trial of Trastuzumab and Capecitabine in patients with HER2 expressing metastasized pancreatic cancer

Andre Mihaljevic, Peter Büchler*, Jan Harder, Ralf Hofheinz, Michael Gregor, Stephan Kanzler, Wolff Schmiegel, Volker Heinemann, Esther Endlicher, Günter Klöppel, Thomas Seufferlein and Michael Geissler

BMC Surgery 2009, 9:1  doi:10.1186/1471-2482-9-1

Pre-publication versions of this article and reviewers' reports

Original Submission - Version 1 Manuscript 03 Jun 2008
Resubmission - Version 2 Manuscript Author's comment 03 Jun 2008
Reviewer's Report Sjoerd Rodenhuis 14 Nov 2008
Resubmission - Version 3 Manuscript Author's comment 19 Nov 2008
Editorial acceptance 29 Dec 2008
Published 08 Jan 2009